Phase 3 Data for Incyte's Retifanlimab (Zynyz ®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet

1 day ago 4
Read Entire Article
  1. Homepage
  2. Finance
  3. Phase 3 Data for Incyte's Retifanlimab (Zynyz ®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet

Related

Health Catalyst's SWOT analysis: data analytics firm navigates healthcare shifts

Health Catalyst's SWOT analysis: data analytics firm navigat...

35 minutes ago 0
Atlassian director Scott Farquhar sells shares worth $1.53 million

Atlassian director Scott Farquhar sells shares worth $1.53 m...

35 minutes ago 0
Atlassian CEO Michael Cannon-Brookes sells shares worth $1.53 million

Atlassian CEO Michael Cannon-Brookes sells shares worth $1.5...

35 minutes ago 0

Trending

1. dax whitney
2. athletics vs royals
3. twins vs astros
4. split
5. orioles game today
6. white sox vs rangers
7. baltimore weather
8. baghdad
9. airline cancels flights
10. rory mcilroy

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

4 months ago 265
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

3 months ago 147
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

5 months ago 145
TOUS les JOURS Opens in Henderson!

TOUS les JOURS Opens in Henderson!

4 months ago 114
Sole mates: Find the perfect shoes for your fitness journey

Sole mates: Find the perfect shoes for your fitness journey

4 months ago 109
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved